Patents by Inventor Ashok Omray

Ashok Omray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHLOROTHIAZIDE, CHLOROTHIAZIDE SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20110263579
    Abstract: The present invention relates to an improved process for the preparation of Chlorothiazide and pharmaceutically acceptable salts thereof. The present invention relates to novel polymorphs of Chlorothiazide and Chlorothiazide salts, in particular Chlorothiazide sodium. The present invention further relates to pharmaceutical compositions comprising Chlorothiazide and Chlorothiazide salts, in particular Chlorothiazide sodium and process for preparation thereof.
    Type: Application
    Filed: April 21, 2011
    Publication date: October 27, 2011
    Applicant: USV Limited
    Inventors: Dhananjay Govind Sathe, Kamlesh Digambar Sawant, Tushar Anil Naik, Ashok Omray, Yogendra Madhav Agashe, Pragati Tukaram Patade, Sunil Suresh Jog
  • Crosslinked Polymers
    Publication number: 20110159087
    Abstract: Disclosed herein are pharmaceutical compositions comprising wet granulated bile acid sequestrants having the general Formula I shown, and their process of preparation. The present invention also discloses process for preparation of Colesevelam hydrochloride, an antilipemic agent.
    Type: Application
    Filed: September 2, 2009
    Publication date: June 30, 2011
    Inventors: Dhananjay Govind Sathe, Harish Kashinath Mondkar, Mantripragada Narayan Rao, Samadhan Daulat Patil, Tanaji Shamrao Jadhav, Ashok Omray, Varsha Shashank Choudhary, Yogesh Sharad Bhide
  • Pharmaceutical compositions comprising phosphate-binding polymer
    Patent number: 7964182
    Abstract: The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Disclosed are compositions comprising wet granulated Sevelamer carbonate free of added metal ions and/or added monovalent anion source.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: June 21, 2011
    Assignee: USV, Ltd
    Inventors: Ashok Omray, Varsha Shashank Choudhary, Yogesh Sharad Bhide
  • Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
    Publication number: 20110081413
    Abstract: The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Disclosed are compositions comprising wet granulated Sevelamer carbonate free of added metal ions and/or added monovalent anion source.
    Type: Application
    Filed: January 22, 2010
    Publication date: April 7, 2011
    Inventor: Ashok Omray
  • Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
    Publication number: 20110064820
    Abstract: The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Disclosed are compositions comprising wet granulated Sevelamer carbonate free of added metal ions and/or added monovalent anion source.
    Type: Application
    Filed: December 1, 2010
    Publication date: March 17, 2011
    Inventors: Ashok Omray, Varsha Shashank Choudhary, Yogesh Sharad Bhide
  • NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20100086590
    Abstract: The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.
    Type: Application
    Filed: October 8, 2009
    Publication date: April 8, 2010
    Applicant: USV Limited
    Inventors: Deepak Anant Hegde, Santosh Sadashiv Chothe, Imran Shakur Ghogari, Ashok Omray